COMP <GO>
HSTM vs AAPL // REVENUE GROWTH (YOY)
HealthStream Inc. (NASDAQ) VS. Apple Inc. (NASDAQ) • 15-METRIC TALLY: HSTM 3
— AAPL 8
▲ REVENUE GROWTH (YOY) LEADER: AAPL
LAST: $34.58 (+2.61%) • MKT CAP: $1.06B
revenue-growth
4.30%
LAST: $338.32 (-1.83%) • MKT CAP: $4.94T
revenue-growth
15.06%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSTM VS. AAPL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSTM | AAPL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 48.79% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.00% | 81.14% | -76.14 | AAPL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 42.7x | 28.4x | +14.27 | AAPL | /valuation <GO> |
| Free Cash Flow Yield | 5.77% | 2.81% | +2.96 | HSTM | /fcf-yield <GO> |
| Operating Margin | 6.70% | 33.01% | -26.31 | AAPL | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 27.60% | -21.60 | AAPL | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 4.30% | 15.06% | -10.76 | AAPL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.36% | 0.33% | +0.03 | HSTM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 12.48 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | AAPL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 5.08% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.4 | 59.9 | +6.50 | HSTM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.14 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 52.5x | 35.8x | +16.74 | AAPL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.06B | $4.94T | -$4.94T | AAPL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSTM REV | AAPL REV | HSTM GROSS % | AAPL GROSS % | HSTM FCF | AAPL FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $478.83B | — | 48.8% | — | $136.06B |
| FY 2025 | $304.1M | $416.16B | — | 46.9% | $59.6M | $98.77B |
| FY 2024 | $291.6M | $391.04B | — | 46.2% | $56.3M | $108.81B |
| FY 2023 | $279.1M | $383.29B | — | 44.1% | $64.0M | $99.58B |
| FY 2022 | — | $394.33B | — | 43.3% | — | $111.44B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSTM // BETA —
AAPL // BETA 1.14